Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
15.8M
-
Shares change
-
-132K
-
Total reported value, excl. options
-
$21.6M
-
Value change
-
-$203K
-
Put/Call ratio
-
0.02
-
Number of buys
-
11
-
Number of sells
-
-23
-
Price
-
$1.37
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q1 2025
51 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q1 2025.
Apyx Medical Corp - Common Stock (APYX) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.8M shares
of 35M outstanding shares and own 45.16% of the company stock.
Largest 10 shareholders include Archon Capital Management LLC (3.3M shares), Nantahala Capital Management, LLC (3.26M shares), ROYCE & ASSOCIATES LP (2.53M shares), VANGUARD GROUP INC (1.48M shares), Silverberg Bernstein Capital Management LLC (647K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), COMMONWEALTH EQUITY SERVICES, LLC (586K shares), Taylor Frigon Capital Management LLC (514K shares), BlackRock, Inc. (495K shares), and GEODE CAPITAL MANAGEMENT, LLC (358K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.